Market revenue in 2022 | USD 6.0 million |
Market revenue in 2030 | USD 18.6 million |
Growth rate | 15.2% (CAGR from 2022 to 2030) |
Largest segment | Solid-phase synthesis |
Fastest growing segment | PCR-based Enzyme Synthesis |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 36.67% in 2022. Horizon Databook has segmented the South Africa gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
South African market has strong government support as the government recognizes advancements in science & technology as an essential development goal. A number of key initiatives and policies have been deployed in the country for supporting growth of innovation in this domain.
For instance, the South African National Bio-economy Strategy was launched in 2014 for providing a policy framework to support infrastructure and competency development in use of technologies such as synthetic biology.
Similarly, the country’s established regulatory framework for genetically modified organisms has enabled increased feasibility for adoption of gene synthesis and genetic modification technologies. For instance, in April 2020, Inqaba Biotec acquired the first PacBio Sequel II System in Africa to enrich its genetic technology portfolio. These factors are anticipated to drive market growth in South Africa.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa gene synthesis market, including forecasts for subscribers. This country databook contains high-level insights into South Africa gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account